Olfactory Neuroblastoma Treatment in India
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Olfactory Neuroblastoma?
A tumor that develops in the nasal cavity is called olfactory neuroblastoma, also known as esthesioneuroblastoma. The sensation of smell is produced by neurons and other tissue in the nasal cavity. This kind of tumor begins in the nasal cavity and can grow into the nearby eyes and brain. Olfactory neuroblastoma can potentially extend to other regions of the body, including the neck, lungs, and bones.
What can I expect if my parents have Olfactory Neuroblastoma?
The following warning signs and symptoms could be markers of olfactory neuroblastoma. Watery eyes, nosebleeds, congestion or stuffiness that worsens or persists, nose obstruction, postnasal drip, or nasal discharge in the throat, and eye pain, pus from the nose, numbness in the face or teeth, loose teeth, diminished smell, or changes in eyesight, • Problem opening the mouth; • Pain or pressure in the ears; • Enlarged neck lymph nodes
What are the Common Symptoms of Olfactory Neuroblastoma?
Symptoms of olfactory neuroblastoma include:
- Loss of smell perception
- Nosebleeds that happen often
- Breathing through the nose with difficulty
- As the cancer spreads, it may result in headaches, ear pain, vision loss, and eye pain
Causes, Risk Factors and Complications of Olfactory Neuroblastoma
CausesThe precise cause of olfactory neuroblastoma has not been determined by experts. Generally speaking, DNA alterations in cells cause cancer. The instructions that inform a cell what to do are encoded in its DNA. The modifications instruct the cells to rapidly produce a large number of new cells. When healthy cells would normally die, the alterations allow the cells to survive. Too many cells are produced as a result.
The cells may accumulate into a mass known as a tumor. Healthy body tissue may be invaded and destroyed by the tumor as it grows. Cells may eventually separate and disperse throughout the body.
Risk FactorsIt is thought to be a major risk factor to work in areas where one is exposed to wood dust, metal dusts (nickel, cadmium), wheat, glues, formaldehyde, and other solvents. Olfactory neuroblastoma risk may also be raised by exposure to tobacco smoke.
Complications
The complications of Olfactory Neuroblastoma include:
- Blockage of the nose
- Pain and pressure in the sinuses
- Epistaxis (bleeding noses)
- Pain in the face
- Eye discomfort and enlargement
- Issues with vision
- Numbness in the face
- Excruciating headaches
- Convulsions
- Impairment of cognition
- Unbalanced hormones (SIADH)
- Spreading to other organs, or metastasis: Participation of lymph nodes, metastases to the bones and metastasis to the liver
Connect with our advisor for a PRIORITY response
Latest Research and Technologies in the Treatment of Olfactory Neuroblastoma in India.
A new medication called lorlatinib, which was first created to treat adult lung cancers, showed significant promise in early 2023 for treating juvenile cancer neuroblastoma when it is caused by a particular mutation in a protein called ALK.
Certain genetic changes, such as those in the ALK gene, frequently cause neuroblastomas to proliferate. Up to 15% of neuroblastoma patients had the altered ALK gene at diagnosis. High-risk neuroblastoma frequently has these mutations, and children whose malignancies have returned frequently have more of them in their tumors. Physicians can check for these mutations in the clinic and determine which individuals will benefit from particular therapies.
Olfactory Neuroblastoma Prevention Tips
Although the precise origin of olfactory neuroblastoma is unknown, evidence points to a possible connection with chemical exposure. People who are exposed to dangerous chemicals and particles at work or through other activities are more likely to develop malignancies of the nasal cavity, according to research. Wood dust, wheat, glues, nickel and cadmium dust, formaldehyde, and other solvents are a few potential offenders. The development of an olfactory neuroblastoma may potentially be influenced by tobacco smoke. Steer clear of these chemicals as much as you can to protect yourself.
Treatment options for Olfactory Neuroblastoma
Chemotherapy: Chemotherapy may be used in situations when the tumor has migrated to other body areas. The most often prescribed chemotherapeutic medications for neuroblastoma include vincristine, carboplatin, doxorubicin, cyclophosphamide, and cisplatin.
Cost Start From USD 600 - USD 700Explore Options
Typically, chemotherapy is a systemic treatment. This implies that the medications enter the bloodstream and travel throughout the body to kill cancer cells, including ones that may have separated from the main tumor. The medications can be administered intravenously (IV) or orally. The medications may occasionally be administered safely using a specialized tool known as a central venous catheter. When chemotherapy begins, it is often implanted during surgery and kept there until the end of the course of treatment.
Radiation therapy: Some olfactory neuroblastoma tumors may be treated with radiation therapy. Radiation therapy may be used as the primary treatment or to help lower the likelihood of tumor recurrence following surgery. The success rates for radiation therapy are 90–95% in stage I, 85–90% in stage II, and 75–80% in stage III. The patient is recommended to see the doctor for follow-up every three months following radiation therapy.
Olfactory neuroblastoma is diagnosed by examining the nasal cavity using a number of various scanning techniques. These consist of MRIs, CT scans, and X-rays. A biopsy may be performed by a physician to obtain further information. To ascertain the type of cancer present, a tissue sample is taken and examined under a microscope.
Since neuroblastoma occurs near important structures, patients may require rehab for the following reasons.
Patients may experience changes in their sense of smell due to the tumor's proximity to the olfactory nerves, necessitating olfactory training or adaption techniques. Dryness in the nasal passages is one of the adverse effects of radiation therapy that may necessitate the adoption of extra management techniques. exercises to enhance the function of the muscles of the face, control pain, and encourage the repair of soft tissues. addressing any speech issues that can result from the disruption of surrounding structures after surgery. activities that aid in retraining the sense of smell, if it has been severely compromised. Advice on controlling nutritional requirements in light of possible swallowing issues
The only treatment option is surgery, radiation therapy, and chemotherapy. The most often prescribed chemotherapeutic medications for neuroblastoma include vincristine, carboplatin, doxorubicin, cyclophosphamide, and cisplatin.
Instantly Connect with our Specialists
Hospitals for Olfactory Neuroblastoma in India
Apollo Hospitals Bannerghatta
Bangalore, India
Apollo Hospitals Bannerghatta located in Bengaluru, India is accredited by JCI, NABH. Also listed below are some of the most prominent infrastructural details:
- Bed Capacity is 250
- Largest and most sophisticated sleep laboratory in the world
- Technological powerhouse with latest equipments
- 120 slice CT angiogram
- 3 Tesla MRI
- Low energy & High energy Linear Accelerators
- Navigation System in surgical procedures
- 4-D Ultrasound for 4 dimensional sonography
- Digital Fluoroscopy
- Gamma Camera
- Stereotactic Robotic Radio- surgery
- Autologous Bone Marrow Transplantation
- Robotic assisted surgeries
- Thallium Laser-First in India
- Holmium Laser-First in South India
- Digital X-Ray-First in Karnataka
- 100 plus consultants
- Uses Y shaped stent for tracheoesophageal fistula
- Four autologous chondrocyte implantations procedure is performed and several more like Spinal angiolipoma excision, Tibial tuberosity shift with MPSL reconstruction
- Biggest series of airway stents in India
- The Minimal Access Surgery Centre (MASC) centre of excellence
HCG Kalinga Rao Road
Bangalore, India
HCG Kalinga Rao Road located in Bengaluru, India is accredited by NABH, NABL. Also listed below are some of the most prominent infrastructural details:
- Diagnostic facility equipped with state-of-the-art imaging technologies, such as 3T MRI, SPECT, PET-CT
- Specialty laboratories provide state-of-the-art diagnostic facilities with expertise in oncology testing
- The services provided under medical oncology include Haemato oncology, Pediatric oncology, Breast health, Preventive oncology, Daycare chemotherapy
- Radiation oncology department adopts advanced technologies like CyberKnife Robotic Radiosurgery, TomoTherapy-H, Da Vinci, which allows cancer to be targeted with high accuracy
- First Cancer Centre in India to introduce PET-CT technologies and Cyclotron
- Consists of several beds and OTs with the latest equipment that meet high standards of sterility, and also comply with all international standards on operation theatre designs
- Access to the latest technology like Linear Accelerator which allows the tumor to be treated with pinpoint accuracy
- Equipped with Agility-Synergy linear accelerator, which allows accurate, image-guided radiotherapy to be provided safely and in a short time.
- Have a unique facility that has BMT suites and a unique hemato-pathology lab. Conditions like Multiple Myeloma, Immune Deficiency Disorders, Leukaemia, Lymphomas, Aplastic Anaemia, Childhood Leukaemia, and certain Pediatric Cancers can be treated with Bone Marrow Transplants at the unit.
- Ortho-Oncology clinic to be the first-of-its-kind in Bangalore, offering dedicated care for Musculoskeletal tumors
- Round-the-clock extensive patient service helping diagnose cancer
- Automated Breast Volume Scanner is the latest technology used for breast cancer detection
- RTISTE linear accelerator used for various treatment approaches, including 3D conformal radiation therapy, Stereotactic
- Radiosurgery (SRS), Intensity-Modulated Radiation Therapy (IMRT), and Stereotactic Body Radiotherapy
Sarvodaya Hospital and Research Centre
Faridabad, India
Sarvodaya Hospital and Research Centre located in Faridabad, India is accredited by NABH, NABL. Also listed below are some of the most prominent infrastructural details:
- Sarvodaya Hospital has a 500 bed capacity which is inclusive of 65 ICU beds.
- A dedicated dialysis unit for people with kidney conditions.
- The hospital has a cancer center which makes cancer treatment a seamless process.
- There is an upcoming oncology center in Sarvodaya Hospital Faridabad.
- Technologies such as 128 Slice CT scan, 500 MA X-Ray, 1.5 Tesla MRI and Mammography facility.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose India for Olfactory Neuroblastoma Treatment?
Here are some of the reasons for choosing India:
Due to advancements in medical facilities, such as minimally invasive surgical techniques.
- World-class experts include highly experienced doctors, JCI, and NABH-accredited healthcare institutions.
- Compared to other countries, treatment in Indian hospitals is cost-effective.
- Indian hospitals provide international patient services, including a multilingual support system.
- Improved treatment methods and biological therapies.
Frequently Asked Questions
Yes, a group of specialists including radiation oncologists, neurosurgeons, and head and neck surgeons collaborate to create a customized treatment plan for each patient. With treatment, the majority of patients with olfactory neuroblastoma recover.
With skilled neurosurgeons, oncologists and cutting-edge medical technology, India has demonstrated significant success rates in treating olfactory neuroblastoma. The nation's healthcare institutions offer top-notch treatment alternatives, guaranteeing successful outcomes for many patients.
Yes, many Indian hospitals offer the following for olfactory neuroblastoma treatment:
- Advanced diagnostic tools like MRI, CT scan, electromyography, and PET scan for accurate neurofibroma diagnosis.
- Skilled neurologist, oncologist and surgeons for olfactory neuroblastoma.
- Advanced radiation therapy and chemotherapy procedures.
- Comprehensive post-surgery care and rehabilitation for long-term health benefit.
Always consider the following factors when selecting Indian hospitals:
- Hospitals that are accredited (authorised by JCI and NABH).
- Patient reviews and success rates.
- Hospitals that provide seamless care to patients from abroad.
In general, olfactory neuroblastoma treatment has much improved in India. The success rate largely depends on how early diagnosis is made. The 5-year overall survival for olfactory neuroblastoma has been reported to be between 70% to 90%, indicating a positive long-term survival rate. Recurrence is common, though, with a 10-year disease-free survival rate recorded.
You need to keep an eye out for the following signs in them:
- Obstruction of the nose or difficulty breathing through it
- Bleeding noses
- Eye bulge or pain around the eyes
- A headache
- Runny nose and nasal leakage (postnasal drip)
- Congestion or stuffiness that doesn't improve or grows worse
- Eyes that are watery
- Vomit from the nose
- Numbness in the face or teeth
- Anosmia, or a diminished sense of smell, loose teeth
- Vision loss or alteration
- Having two eyes
- Pressure or pain in the ears
- Having difficulty expanding your mouth
- Neck lymph node enlargement
Patients with Olfactory Neuroblastoma may experience long-term consequences such as irreversible loss of smell (anosmia), changes in vision, cognitive impairment, and the possibility of spread of tumor to other parts of the body.
- The most likely course of treatment for your parent with neuroblastoma is combination of surgery with radiation and/or chemotherapy:
- After surgery, adhere to your doctor's instructions. After surgery, you should pay particular attention to areas of skin that have been stitched or stapled
- Consult your provider as advised. To help prevent problems from this illness, follow-up visits are crucial
- Be mindful of the symptoms. Inform your healthcare physician right away if you observe your parents exhibiting a recurrence of an olfactory neuroblastoma
- Consult doctor to provide postoperative rehab therapy to regain most of the function of smell and other associated organ functions